PROF · Profound Medical Corp.
$6.63
-0.04 (-0.60%)
At close · Aug 14
Market Cap
$242.21M
Shares
36.53M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Frank Baylis | director | Appointed | 2026-03-10 |
| Kris Shah | Board | Resigned | 2026-03-10 |
Key facts
CIK
1628808
CUSIP
74319B502
13F (30d)
56 filings
56 filers
Visit website
Investor relations